ESBATech, a Novartis company is founded in 1998, operates from its headquarter in Wagistrasse 12 Schlieren-Zurich, 8952, CH. The company operates in the Hospitals & Healthcare, Medical Practices sector.
ESBATech, a Novartis company specializes in Biologics research and development, Clinical Proof-of-Concept, Pathways research, Biologics technologies, and offers services including Proprietary antibody fragment technology, New and effective treatments for sight-threatening eye diseases.
Total Rounds
US$ 22M
Last Round
US$ 22M
Rounds
1